U.S. Tobacco Stock News

If you are wondering whether Molson Coors Beverage shares are pricing in too much pessimism or offering quiet value, this is a good moment to take a closer look. The stock recently closed at US$45.87, with returns of a 4.6% decline over 7 days, an 11.4% decline over 30 days, a 3.2% decline year to date, a 21.0% decline over 1 year, and a 2.5% decline over 3 years, compared with a 10.0% gain over 5 years, which may have changed how investors see its risk and potential. Recent coverage of...

If you are wondering whether Sysco is priced fairly today or if there is still value left on the table, this article walks you through what the numbers are really saying about the stock. Sysco shares last closed at US$84.29, with returns of 16.1% year to date and 16.3% over the past year, despite a 4.2% decline over 7 days and a 2.6% decline over 30 days that may be shifting how some investors see the risk and reward balance. Recent coverage has focused on Sysco's position as a major...

Four Corners Property Trust (NYSE:FCPT) has acquired automotive service properties in Texas and Indiana. Each property is operated under a long term triple net lease with a national automotive service tenant. The transactions extend FCPT’s reach beyond casual dining into essential, car focused retail locations. For you as an investor, these new deals highlight how Four Corners Property Trust, known for its net lease portfolio centered on restaurants, is adding more automotive service assets...

Coherus Oncology (CHRS) just posted its FY 2025 numbers with Q4 revenue of US$12.7 million and a basic EPS loss of US$0.39, while trailing 12 month figures show revenue of US$42.2 million and a basic EPS loss of US$1.56. Over recent quarters, the company has seen revenue move from US$7.6 million in Q1 2025 to US$12.7 million in Q4 2025, with quarterly basic EPS losses in a tight band around US$0.38 to US$0.41. This keeps the focus squarely on how efficiently each extra dollar of sales is...

In February 2026, Innoviva, Inc. reported fourth-quarter 2025 revenue of US$114.61 million and net income of US$164.15 million, alongside full-year revenue of US$411.33 million and net income of US$271.17 million, all higher than the prior year. An interesting feature of this release is the sharp increase in basic earnings per share from continuing operations, with quarterly EPS rising to US$2.19 and full-year EPS reaching US$4.02 compared with the previous year. We’ll now explore how...

Arcus Biosciences recently reported full-year 2025 results, with revenue of US$247 million versus US$258 million in 2024 and a net loss of US$353 million, while also granting new employee equity awards under its 2020 Inducement Plan. More importantly for the story, Arcus outlined encouraging new clinical data and expansion plans for its HIF-2α inhibitor casdatifan in kidney cancer, alongside moves into inflammatory and autoimmune diseases that could reshape how investors view its pipeline...

Tilray Brands has completed its acquisition of BrewDog Brewing Australia, expanding its beverage platform into the Asia Pacific region. The deal adds an Australian production facility, bar network, and new distribution channels to Tilray’s existing BrewDog UK relationship. This move is described by the company as its most significant international step in beverages so far. Tilray Brands, traded as NasdaqGS:TLRY, now pairs its existing BrewDog UK exposure with a direct operating footprint in...

OPENLANE (OPLN) has drawn investor attention after recently trading around US$28.34. Its mixed share performance over the past month and past 3 months has prompted closer scrutiny of its wholesale used vehicle marketplace business. See our latest analysis for OPENLANE. Looking beyond the recent pullback, OPENLANE’s 1 day share price return of 1.73% and 30 day share price return of a 3.70% decline contrast with a 1 year total shareholder return of 36.58% and 3 year total shareholder return of...

Kohl's (KSS) has wrapped up FY 2026 with fourth quarter revenue of US$5,173 million and basic EPS of US$1.12, anchored by net income of US$125 million. Trailing 12 month basic EPS sits at US$2.43 on revenue of US$15,527 million. Over the past few quarters, the company has seen quarterly revenue move from US$3,233 million in Q1 2026 to US$5,173 million in Q4 2026, with basic EPS ranging from a loss of US$0.14 in Q1 2026 to US$1.12 in Q4 2026. Trailing 12 month EPS has risen from US$1.09 at Q1...

Repay Holdings FY 2025 results: revenue steady, losses weigh on margins Repay Holdings (RPAY) has wrapped up FY 2025 with Q4 revenue of US$78.6 million and a basic EPS loss of US$1.71, capping a year in which trailing 12 month revenue came in at US$309.3 million alongside a net loss of US$256.7 million. Over recent quarters the company has seen quarterly revenue move in a tight band between US$75.6 million and US$79.1 million, while quarterly basic EPS has ranged from a loss of US$1.71 to a...

Unusual Machines (UMAC) has wrapped up FY 2025 with Q4 revenue of US$4.9 million, Basic EPS of a US$0.29 loss, and net income excluding extra items of a US$10.6 million loss, setting a clear snapshot of where the business stands today. Over recent periods the company has seen revenue move from US$2.0 million in Q4 2024 to US$4.9 million in Q4 2025. Quarterly EPS has ranged from a US$2.70 loss in Q4 2024 to a US$0.05 profit in Q3 2025 and back to a US$0.29 loss in the latest quarter,...

Inspired Entertainment (INSE) has just wrapped up FY 2025 with Q4 revenue of US$77.2 million and a basic EPS loss of US$0.25, alongside trailing twelve month revenue of US$304.1 million and a TTM basic EPS loss of US$0.58. Over recent quarters, the company has seen revenue move between US$60.4 million and US$86.2 million, while basic EPS has ranged from a small loss of US$0.00 in Q1 2025 to a profit of US$2.28 in Q4 2024, before settling back into losses through 2025. For investors, these...

Willis Lease Finance (WLFC) has just wrapped up FY 2025 with fourth quarter total revenue of US$193.6 million and basic EPS of US$1.58, while trailing twelve month revenue landed at US$730.2 million and EPS at US$16.00. Over recent periods, the company has seen quarterly revenue move from US$149.1 million in Q4 2024 to US$153.4 million in Q1 2025, US$191.9 million in Q2, US$180.0 million in Q3, and US$193.6 million in Q4, with basic EPS shifting from US$2.97 in Q4 2024 to US$2.34, US$8.68,...

Why Landstar System Is On Investors’ Radar Landstar System (LSTR) has drawn attention after recent share performance, with the stock delivering a small gain over the past 3 months but a modest decline over the past month. Against that backdrop, investors are weighing how the company’s transportation management model and financial profile, including annual revenue of US$4,757.445 million and net income of US$115.007 million, compare with the current price of US$151.84. See our latest analysis...

Voyager Therapeutics (VYGR) has released its FY 2025 numbers with Q4 revenue of US$15.3 million and a basic EPS loss of US$0.47, alongside a trailing twelve month revenue figure of US$40.4 million and basic EPS of US$2.04 loss. The company has seen quarterly revenue range from US$5.2 million to US$15.3 million over FY 2025 while basic EPS losses moved between US$0.47 and US$0.57, all against a backdrop of TTM net income of US$119.7 million loss and revenue growth running at about 7.8% per...

LandBridge Company LLC recently reported full-year 2025 results showing revenue of US$199.09 million and net income of US$30.13 million, alongside a 20% dividend increase and a new US$50 million share repurchase authorization running through 2027. This combination of stronger profitability, higher cash returns to investors, and a multi-year buyback plan highlights the company’s emphasis on shareholder-focused capital allocation. Next, we’ll examine how LandBridge’s higher dividend fits into...

Esperion Therapeutics (ESPR) closed FY 2025 with fourth quarter revenue of US$168.4 million and basic EPS of US$0.26, alongside net income of US$61.8 million, marking a clean break from the losses seen earlier in the year. Over the past few quarters, the company has seen revenue move from US$51.6 million in Q3 2024 to US$64.9 million in Q1 2025, US$82.4 million in Q2, US$87.3 million in Q3 and then US$168.4 million in Q4. Basic EPS shifted from a loss of US$0.15 in Q3 2024 through losses of...

Limited-edition collaboration and fresh dividend decision draw attention to Dillard's stock Dillard's (DDS) has rolled out the Amanda Jones Vaughan x Antonio Melani limited-edition collection across its stores and website, and has also affirmed a regular cash dividend, giving investors fresh company specific developments to watch. See our latest analysis for Dillard's. Despite a recent 30 day share price return of a 10.25% decline and a 90 day share price return of an 18.14% decline from a...

Why Rambus Stock Is Back in Focus Rambus (RMBS) is in the spotlight after its February 2 update on a supply chain disruption affecting Q1 2026 performance, followed by a securities law investigation that has added another source of uncertainty for shareholders. See our latest analysis for Rambus. Rambus shares have been under pressure in recent months, with a 30 day share price return of 16.3% and a 90 day share price return of 16.1%, even as the 1 year total shareholder return sits at 73.8%...

Hewlett Packard Enterprise (HPE) opened fiscal Q1 2026 with revenue of US$9.3 billion and basic EPS of US$0.32. This compares with a trailing twelve month picture that includes a basic EPS loss of US$0.18 on revenue of US$35.7 billion. Over recent quarters the company has reported revenue of US$8.5 billion in Q4 2024, US$7.9 billion in Q1 2025, US$7.6 billion in Q2 2025, US$9.1 billion in Q3 2025, US$9.7 billion in Q4 2025 and now US$9.3 billion in Q1 2026. Quarterly basic EPS has ranged from...

Yext (YEXT) has wrapped up FY 2026 with fourth quarter revenue of US$112.0 million and basic EPS of US$0.03, alongside trailing twelve month revenue of US$446.6 million and EPS of US$0.31 that reflect its move into profitability over the past year. The company has seen quarterly revenue hold in a tight band between US$109.5 million and US$113.1 million since early FY 2026, while basic EPS has ranged from US$0.01 in Q1 to US$0.22 in Q2, a clear shift from losses in FY 2025 where quarterly EPS...

If you are wondering whether Select Medical Holdings is fairly priced or offering value at today’s levels, you are not alone. This article is built to help you judge the stock through a clear valuation lens. The share price closed at US$16.26 most recently, with returns of 0.0% over 7 days, 3.6% over 30 days, 9.7% year to date, a 2.5% decline over 1 year, a 26.2% gain over 3 years, and a 6.4% decline over 5 years. This gives a mixed picture for investors weighing risk and potential...

Uranium Energy (UEC) has posted Q2 2026 revenue of US$20.2 million, with a basic EPS loss of US$0.03 and net income loss of US$13.9 million, providing a clear snapshot of where the business stands today. Over recent quarters, the company has reported revenue between US$0 and US$49.75 million while basic EPS has ranged from a loss of US$0.02 to a loss of US$0.07. This gives investors a wide view of how the top line and per-share results have shifted through different periods. With forecasts...

LifeMD (LFMD) has wrapped up FY 2025 with Q4 revenue of about US$46.9 million and basic EPS of around a US$0.04 loss, alongside trailing twelve month revenue of roughly US$194.1 million and basic EPS of about a US$0.32 loss. Over the past few reported periods, revenue has moved from US$64.3 million in Q4 2024 to US$65.7 million in Q1 2025, then US$61.1 million in Q2, US$60.2 million in Q3 and US$46.9 million in Q4. Quarterly EPS shifted from roughly a US$0.02 loss in Q4 2024 to a small profit...